Neuroscience

CRISPR technology targets mood-boosting receptors in brain

An estimated 13 percent of Americans take antidepressant drugs for depression, anxiety, chronic pain or sleep problems. For the 14 million Americans who have clinical depression, roughly one third don't find relief with antidepressants.

Parkinson's & Movement disorders

Longtime antidepressant could slow Parkinson's

Michigan State University scientists now have early proof that an antidepressant drug that's been around for more than 50 years could slow the progression of Parkinson's.

Diseases, Conditions, Syndromes

Study reveals most effective drugs for common type of neuropathic pain

More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information to guide a physician's ...

Psychology & Psychiatry

New theory may explain cause of depression and improve treatments

A new area in depression research suggests dysfunction in mitochondria—the main source of energy for cells—could lead to major depression. Published in Frontiers in Neuroscience, this new insight to long-held theories ...

Psychology & Psychiatry

Teens and depression—a back-to-school concern

With many teens heading back to school, peer pressure and academic expectations are once again a reality. These added pressures can cause ups and downs during what can be an already tumultuous time of life. For some teens, ...

page 1 from 13